BIM
HALO icon

Bogle Investment Management’s Halozyme HALO Stock Holding History

Bogle Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-377,467
Closed -$7.39M – 309
2018
Q1 		$7.39M Sell
377,467
-146,834
-28% -$2.84M 0.56% 74
2017
Q4 		$10.6M Buy
+524,301
New +$9.64M 0.78% 52
2015
Q3 		– Sell
-200,084
Closed -$4.52M – 384
2015
Q2 		$4.52M Buy
+200,084
New +$3.52M 0.34% 112

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bogle Investment Management's HALO Position: Q2 2018 in Review

Bogle Investment Management sold out of Halozyme (HALO) in Q2 2018, closing a stake of 377,467 shares — an estimated $7.39M sold.

Bogle Investment Management first reported a position in HALO in Q2 2015 and held it in 3 quarters. The position peaked at $10.6M in Q4 2017. 193 funds tracked by Wall St. Rank hold HALO as of Q2 2018.

  • Bogle Investment Management reported no remaining Halozyme position as of Q2 2018 after selling out during the quarter.
  • Bogle Investment Management sold 377,467 Halozyme shares in Q2 2018, an estimated $7.39M.
  • Bogle Investment Management first reported a position in Halozyme in Q2 2015 and held it in 3 quarters.
  • Bogle Investment Management's Halozyme position peaked at $10.6M in Q4 2017.
  • 193 funds tracked by Wall St. Rank held Halozyme as of Q2 2018.

Based on Bogle Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.